Immune-mediated Clearance of Senescence Cells in Oncology

Time: 9:30 am
day: Day Two


  • Explore targeting an immune-oncology target expressed on senescent cells to develop novel senotherapies
  • Examine the clinical outcome: Improve SOC in the oncology field by eliminating therapy-induced senescence in cancer
  • An exclusive look at Rejuversen’s development of a biological medicine